FDA clears blood test to detect signs of Alzheimer's disease
FDA clears blood test to detect signs of Alzheimer's disease
Source: The Signal
Date: 08/25/2026 1:09pm
Article Summary:
FDA Clears Roche’s Elecsys pTau-217 Blood Test to Detect Alzheimer’s Disease Biomarker Signals
The FDA has cleared Roche’s Elecsys pTau-217 blood test for adults 55 and older who show signs of or report cognitive decline. The test measures a blood biomarker associated with Alzheimer’s progression and offers a less invasive diagnostic option that will be available through primary care and specialist offices, Labcorp, and Quest Diagnostics.
Read article here »
Date: 08/25/2026 1:09pm
Article Summary:
FDA Clears Roche’s Elecsys pTau-217 Blood Test to Detect Alzheimer’s Disease Biomarker Signals
The FDA has cleared Roche’s Elecsys pTau-217 blood test for adults 55 and older who show signs of or report cognitive decline. The test measures a blood biomarker associated with Alzheimer’s progression and offers a less invasive diagnostic option that will be available through primary care and specialist offices, Labcorp, and Quest Diagnostics.
Read article here »